Action:
Changes to access and labeling requirements
General Information
Action Summary |
The amended regulations will:
1) Amend section 210 to clarify the process by which a pharmacist, pharmacy technician, or an employee of the pharmaceutical processor or cannabis dispensing facility who has routine access to confidential patient data and who has signed a patient data confidentiality agreement with the processor or dispensing facility, may determine eligibility for access to the processor or facility.
2) Amend section 310 to eliminate certain requirements to be included on a product label if the information is found on the batch label.
|
Chapters Affected |
Only affects this chapter.
|
Executive Branch Review |
This Action is exempt from Article 2 of the Administrative Process Act.
The normal executive branch review process is not required. As such, it can be submitted directly for publication and
is effective upon publication.
Exempt Citation:
This action is exempt under 54.1-3442.6 of the Code.
|
RIS Project |
Yes [7130] |
New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
Stage ID |
Stage Type |
Status |
9566
|
Final
|
Stage complete. This regulation became effective on 05/25/2022. |
Contact Information
Name / Title:
|
Caroline Juran, RPh
/
Executive Director
|
Address:
|
9960 Mayland Drive
Suite 300
Henrico, VA 23233
|
Email Address:
|
caroline.juran@dhp.virginia.gov
|
Phone:
|
(804)367-4456
FAX: (804)527-4472
TDD: ()-
|
This person is the primary contact for this board.